3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Neoplasm Metastasis
5
Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
HER2-positive Breast Cancer
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Patient Preference
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Inflammatory Breast Neoplasms
1
Interventions
pembrolizumab
3
Nivolumab
3
Ifosfamide
3
Doxorubicin
3
AZD 6244
3
selinexor
2
pazopanib
2
fludarabine phosphate
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
tazemetostat
1
metarrestin
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Injections
1
Etoposide
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Ado-Trastuzumab Emtansine
×
1 year
×
Clear all
No trials found.